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Background. Mitochondrial DNA (mtDNA) variation in single hematopoietic cells, muscle fibers, oocytes, and from tiny
amount of tumor tissues and degraded clinical specimens has been reported in many medical publications. External DNA
contamination, notoriously difficult to avoid, threatens the integrity of such studies. Methodology/Principal Findings.
Employing a phylogenetic approach, we analyzed the geographic origins of mtDNA sequence anomalies observed during
multiple studies of mtDNA sequence variation in a total of 7094 single hematopoietic cells. 40 events with irregular mtDNA
patterns were detected: eight instances (from seven different haplotypes) could be traced to laboratory personnel; six cases
were caused by sample cross-contamination. The sources of the remaining events could not be identified, and the anomalous
sequence variation referred to matrilines from East Asia, Africa, or West Eurasia, respectively. These mtDNA sequence
anomalies could be best explained by contamination. Conclusions. Using the known world mtDNA phylogeny, we could
distinguish the geographic origin of the anomalous mtDNA types, providing some useful information regarding the source of
contamination. Our data suggest that routine mtDNA sequence analysis of laboratory personnel is insufficient to identify and
eliminate all contaminants. A rate of 0.6% of external contamination in this study, while low, is not negligible: Unrecognized
contaminants will be mistaken as evidence of remarkable somatic mutations associated with the development of cancer and
other diseases. The effective contamination rate can increase by a factor of more than an order of magnitude in some studies
that did not institute high standards. Our results are of particular relevance to mtDNA research in medicine, and such an
approach should be adopted to maintain and improve quality control in single-cell analyses.
Citation: Yao Y-G, Bandelt H-J, Young NS (2007) External Contamination in Single Cell mtDNA Analysis. PLoS ONE 2(8): e681. doi:10.1371/
journal.pone.0000681
INTRODUCTION
Mitochondria provide energy to the cell and have important roles
in intracellular signaling and apoptosis and in intermediary
metabolism [1,2]. Each mitochondrion contains many copies of
DNA and its own transcriptional and translational machinery.
Human mtDNA is a 16.6 kb, double-stranded circular molecule,
which encodes 13 oxidative phosphorylation proteins, 22 tRNAs,
and 2 ribosomal RNAs [3]. Mitochondrial dysfunction, due to
mutations in the nuclear or mitochondrial DNAs, cause a wide
range of aging-related diseases as well as specific neurological and
auditory syndromes [2,4,5].
A high frequencyof somatic mtDNAmutations hasbeenreported
in various adult post-mitotic cells and in cancer tissues, implicating
mtDNA sequencevariation inphysiological aging and tumorigenesis
[2,4,6–13]. Based on analyses of mtDNA variation in single cells,
recent studies have provided deeper insight into the somatic
mutation pattern in colorectal mucosa [14,15], muscle fibers [16–
21], cardiomyotes [22], hematopoietic cells [13,23,24], neurons
[25,26], and the segregation pattern of mtDNA mutation in oocytes
and dividing cells [27,28]. The complete mtDNA genome can be
determined in single muscle fibers [21,29]. However, single cell
analyses are technically challenging: the risk of contamination is
omnipresent and can result in anomalous results. Recognition and
elimination of contaminants and their sources is important to
maintain data integrity. Guidelines for ancient DNA protocols
[10,30–35] in principle could be suggested for working with very
small amount of DNA from single cells or clinical specimens.
Recently, we and others have found that the mtDNA data
reported in the medical literature are not free of serious errors
[10,36,37]. Besides misinterpretation and phantom mutations, the
mtDNA sequences reported especially in cancer research [10],
may often be plagued with contamination and sample crossover,
mainly due to the small amount of DNA available from clinical
specimens and insufficient attention to the worldwide mtDNA
phylogeny, which can be useful for a posteriori data assessment
[10,36–40]. In previous studies that have determined the entire
mtDNA sequence in order to identify mutations in a small amount
of cells in comparison to reference cells and which have identified
a correlation between the mutation(s) and biochemical defect
[14,15], the reported mtDNA alterations are highly likely to be
real rather than artifactual and the inferences are convincing.
We have utilized single-cell analysis methods for mtDNA
mutation to examine aging in the hematopoietic system [24,41].
Somatic mutations observed in single hematopoietic cells may
allow tentative estimates of the number of active hematopoietic
stem cells and committed progenitors (HSCs) [23] and the kinetics
of HSCs during transplantation (authors’ unpublished data), as
well as the clonality of leukemic blast cells [13]. Although we have
aspired to high standards and have instituted precautions to avoid
contamination during our experiments, we still encountered
anomalous sequences, and two instances unfortunately went
unnoticed in one of our earlier studies (cf. [42]). Therefore, it
was of interest to systematically examine all potential contamina-
tion events in our recent single-cell studies and to trace their
source. Our comprehensive analysis of 40 cells with anomalous
mtDNA sequences encountered in analysis of a total of 7094 single
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PLoS ONE | www.plosone.org 1 August 2007 | Issue 8 | e681cells revealed that only a minority (35%) derived from laboratory
personnel or sample cross-contamination. The exact sources for
the remaining irregular types with varying matriline origins could
not be identified.
To our knowledge, this constitutes the first report concerning
mtDNA somatic mutations in cancer and normal hematopoietic
cells that systematically (re)analyzed samples that were previously
the target of analysis in a laboratory. An earlier attempt [43]
performed only ‘cosmetic’ changes in some selected samples (such
as JHU_MITO #9) from early studies [44,45], but remained
silent about the most salient case of sample contamination/
confusion involving JHU_MITO #12 [42].
MATERIALS AND METHODS
Subjects
We collected hair or blood samples from all 41 current and past
laboratory members. Individuals no. 1–5 directly handled the
samples and performed the single-cell analysis, whereas the
remaining members (no. 6–41) did not physically contact samples
for single-cell analysis but shared some bench space and office
areas with members no. 1–5 (table 1). The samples for single-cell
analysis were obtained in projects on leukemia [13], trans-
plantation, and family analysis (table S1). All healthy donors and
patients were recruited with informed consent under protocols
approved by the Institutional Review Board of the National Heart,
Lung, and Blood Institute (NHLBI, Bethesda), M.D.
Genomic DNA extraction
Genomic DNA from whole blood samples was extracted by using
QIAamp DNA Mini Kit (Qiagen) according to the manual of the
manufacturer. We plucked a single hair and instantly digested the
hair root (containing follicular sheath material) in 50 mL of lysis
buffer (10 mmol/L Tris-HCl [pH 8.0], 50 mmol/L KCl, 100 mg/
mL Proteinase K, 1% Triton X-100) at 56uC for 1 h, then the
lysate was incubated at 96uC for 8 min to inactivate the proteinase
K. The procedure for single-cell DNA extraction has been
described in detail in our recent studies [13,23]. In brief,
mononuclear cells from peripheral blood were separated by Ficoll
density gradient centrifugation, washed, and stained with re-
spective antibodies. Single cells were sorted into 96-well plates by
flow cytometry and were lysed in 50 mL lysis buffer/well.
mtDNA amplification and sequencing
PCR amplification of single cells was performed in 96-well plates
using the same procedure and condition described in our recent
study [13]. In brief, 5 mL of cell lysates were amplified in 30 mLo f
reaction mixture containing 400 mM of each dNTP, 1 units of
TaKaRa LA Taq
TM , which has proof reading activity (Takara
Bio. Inc.), 0.5 mM of each forward and reverse outer primer
(L15594: 59-CGCCTACACAATTCTCCGATC-39 and H901:
59-ACTTGGGTTAATCGTGTGACC-39). The amplification
was run on the GeneAmp PCR system 9700 (Applied Biosystems,
Foster City, CA) with one denaturation cycle of 94uC for 3 min,
then 35 cycles of 94uC for 30 sec, 52uC for 40 sec and 72uC for
1 min with a 5 sec increase per cycle, and ending with a full
extension cycle of 72uC for 10 min. The second PCR was
performed in 50 mL of reaction mixture containing 400 mMo f
each dNTP, 2 units of TaKaRa LA Taq
TM, 0.5 mM of each
forward and reverse inner primers (L15990: 59-TTAACTCCAC-
CATTAGCACC-39 and H650: 59-GAAAGGCTAGGAC-
CAAACCTA-39), and 5 mL of first PCR product. Amplification
condition for the second PCR included one denaturation cycle of
94uC for 3 min, then 35 cycles of 94uC for 30 sec, 52uC for 40 sec,
and 72uC for 90 sec, ending with a full extension cycle of 72uC for
10 min.
Second PCR products were purified using the QIA quick PCR
purification kit (Qiagen, Valencia, CA) or the ExcelaPure 96-Well
UF PCR Purification Kit (EdgeBiosystems, Gaithersburg, MD).
The purified PCR products were overlap sequenced using the
inner primers (L15996, 59-CTCCACCATTAGCACCCAAAGC-
39; L16209, 59-CCCCATGCTTACAAGCAAGT-39; L16517, 59-
CATCTGGTTCCTACTTCAGG-39; H26, 59-GCATGGA-
GAGCTCCCGTGAGTGG-39; L29, 59-GGTCTATCACCC-
TATTAACCAC-39; L332, 59-CCCGCTTCTGGCCACAG-
CAC-39) and primer H650, as described in our recent study
[13]. Sequencing was performed by using BigDye Terminator v3.1
Cycle Sequencing Kit and was run on a 3100 DNA sequencer
(Applied Biosystems) according to the manufacturer’s manual.
The DNA samples extracted from whole blood (100 ng) and
hair (2 mL of lysate) were amplified by using primer pair L15990/
H650 and the same conditions as the second PCR for single cells.
PCR products were purified by using QIAamp Gel Extraction Kit
and were sequenced in the same way as for single cells.
To discern any reagent contamination and to validate our
technique, we performed two-step PCR in two 96-well plates,
which included the PCR reaction mixture but replaced cell lysate
or first PCR product with ddH2O, and followed the same
procedure as for single cells. We observed no amplification in any
of the 192 wells, indicating absence of contamination of reagents.
In each amplification of single cells from a sample, we also
included one to four negative controls.
mtDNA anomaly recognition and phylogenetic
analysis
We followed a simple approach to pinpoint anomalous mtDNA
sequence in single cells. A cell showing mutations at nearly all
variable sites of the aggregate mtDNA sequence from the
individual’s sample was regarded as anomaly or contamination
(figure 1A, B). The sequence variation of the irregular mtDNA
could be read from all the observed variable sites by filtering those
sites that were present in the aggregate sequence of the single cells
(table S1). Such a filtering strategy places the potential somatic
mutation(s) in the contaminated cell into the inferred sequence of
the contaminant and cannot distinguish the shared heteroplasmic
mutations between the contaminant and the cell. In several cases,
the determination of a cell (lysate from certain well in a 96-well
plate) yielded a sequence different from the aggregate sequence of
single cells from the same sample by many homoplasmic
mutations, and the sequence variation of this mtDNA type was
directly read from the determined sequence. All mtDNA sequence
types of laboratory personnel, samples for single-cell analysis, and
contaminants, were classified relative to the available world
mtDNA phylogeny [46–51]. The ultimate geographic origins of
the matrilines were inferred according to the current continental
distribution of the haplogroups (which are monophyletic clades in
an mtDNA tree). In this context, the phylogenetic method was used
to discern the potential origin of the mtDNA sequence anomalies
rather than to identify spurious genetic alterations in our single-cell
analysis; the phylogeographic information thus provides an
explanation for some of the observed sequence anomalies.
RESULTS
Haplogroup classification of mtDNAs
The classification of 41 mtDNAs from laboratory personnel
revealed various continental sources for these matrilines and was
in general agreement with the claimed geographic origin, with the
Single Cell Contamination
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African provenance (table 1). Ten mtDNAs belonged to eight East
Asian haplogroups (A, D4c1a, D4, D4b, M7b, B4a, B5a, and F1b)
and three mtDNAs to South Asian haplogroups (M5a, M5c, and
R30). Six mtDNAs belonged to African-specific haplogroups (L1b,
L2a1, L2d, L3b, L3e2, and U6a1). The remaining 22 mtDNAs
Table 1. MtDNA sequence variation and haplogroup status in current and past laboratory personnel.
..................................................................................................................................................
Sample Sequence variation Haplo-group Geographic origin
1 16189-16223-16290-16319-73-152-235-263-292-(523-524)delAC A East Asian
2 16147-16173-16223Y-16245-16362-73-191insA-194-199-207-263-489 D4c1a East Asian
3 16126-16148-16294-16304-16519-73-151-263 T2b West Eurasian
4 16311-146Y-263-480 H West Eurasian
5 16154-16311-263-455insT H West Eurasian
6 16126-16362-16519-57insC-64-263 R0a West Eurasian
7 16129-16181A/C-16182A/C-16183A/C-16189-16217-16261-16292-16301-16519-61-62-73-263-(523-524)delAC B4a East Asian
8 16126-16187-16189-16223-16264-16270-16278-16290-16293-16311-16519-73-150-152-182-184-185C-188-
247-263-357-515
L1b Sub-Saharan African
9 16126-16294-16296-16304-16519-73-263-321 T2b West Eurasian
10 16172-16219-16235-16278-16355-16519-73-146-263 U6a1 North African
11 16069-16126-73-151-152-185-228-263-295-462-489 J1c West Eurasian
12 16124-16183A/C-16189-16223-16278-16362-16527-73-263-(523-524)delAC L3b Sub-Saharan African
13 16129-16223-16264-16265C-16518C-16519-73-189R-263-489-(523-524)delAC M5a South Asian
14 16168-16224-16311-16519-73-185-263-497 K1a West Eurasian
15 16129-16192-16223-16234-16362-73-153-195-263-489-(523-524)delAC D4 East Asian
16 263 H2b West Eurasian
17 16217-73-152-195-263 HV2 West Eurasian
18 16114A-16126-16187-16294-16296-16324-16519-73-152-263 T2 West Eurasian
19 16224-16248-16311-16319-16463-16519-73-152-263-(523-524)insAC K1b1a West Eurasian
20 16174-16223-16311-16362-73-152-263-489-(523-524)delAC D4 East Asian
21 16150-16182C-16183C-16189-16311-152-195-263-270 H11 West Eurasian
22 16189-16192-16223-16278-16294-16304-16309-16390-73-146-152-195-263-534 L2a1 Sub-Saharan African
23 16048-16129-16218-16223-16301-16357-55insT-57-59-73-194-263-489-(523-524)delAC M5c South Asian
24 16519-263 H West Eurasian
25 16270-16519-263 H West Eurasian
26 16311-93-263 H West Eurasian
27 16519-263 H West Eurasian
28 16126-16163-16186-16189-16294-16519-73-152-195-263 T1a West Eurasian
29 16129-16145-16223-16297-73-150-263-372-489 M7b East Asian
30 16162-16172-16209-16291-16519-73-263 H1a West Eurasian
31 16092-16223-16319-16356-16362-73-263-489-(523-524)delAC D4b East Asian
32 16093Y-16129-16189-16278-16300-16354-16390-16399-16519-73-146-150-189-195-263-456-573+C L2d Sub-Saharan African
33 16140-16182C-16183C-16189-16266A-16519-73-210-263-(523-524)delAC-593 B5a East Asian
34 16140-16183C-16189-16234-16266A-16519-73-150-210-263-(523-524)delAC B5a East Asian
35 16263-16519-263-477 H1 West Eurasian
36 16126-16294-16296-16304-16519-73-263 T2b West Eurasian
37 16183C-16189-16300-16304-16311-16519-73-150-195-249delA-263-(523-524)delAC-573insCCCCC F1b East Asian
38 16223-16320-16355-16519-73-150-195-263 L3e2 Sub-Saharan African
39 16189-16292-16304-16497-16519-73-263-373 R30 South Asian
40 16145-16176-16224-16233-16311-16456-16519-16527-73-263 K West Eurasian
41 16093Y-16311-16519-263 H West Eurasian
Note: Sequence variation of each individual was determined from a single hair (with the exception of samples 10 and 22 in which genomic DNA from whole blood was
used) and was scored relative to the Cambridge Reference Sequence (CRS) [3]. Suffixes Y and A/C meant heteroplasmy for C and T, A and C, at the respective site.
Suffixes A and C indicated transversions; ‘‘ins’’ and ‘‘del’’ indicated insertions and deletions, respectively. Indels (insertion/deletion) were recorded at the last possible
site. Length mutations of the C-tract in regions 16184–16193 and 303–309 were not included. All samples had 315+C in the second hypervariable segment of mtDNA
control region. The haplogroup status of the samples and geographic origin of the haplogroups were estimated according to the world mtDNA phylogeny as known to
date [46–51,54].
doi:10.1371/journal.pone.0000681.t001
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unrelated lab members (24 and 27) shared the same (frequent)
haplotype belonging to haplogroup H (table 1). The sample group
for single-cell analysis contained 18 matrilines of West Eurasian
origin, eight matrilines of potential Native American ancestry, and
six matrilines of (North or sub-Saharan) African origin (mtDNAs
of the maternally related samples were counted as one matriline;
table S1).
Recognition of mtDNA sequence anomalies
In total, we identified 40 cells with anomalous sequence variation
from a total of 7094 single cells by direct sequence comparison,
although the negative controls included in these experiments
consistently yielded no detectable amplification on 1.5% agarose
gel. The frequency of cell showing anomalous sequence was thus
low (0.6%). Seven members [including three (members 1, 2, and 5)
who handled samples and performed single-cell analysis and four
members (members 8, 15, 17, and 24 or 27) who shared some
bench space and office areas but did not work with the samples in
this study] shared sequence with the anomalous types in eight cells,
thus suggesting contamination. Among them, contamination of
East Asian origin from member 15 (haplogroup D4) occurred
twice. In the two contamination cases caused by members 8 and
17, the determination of the cell lysate showed the exact sequences
of the two members and the sequence of the original cell could not
be recognized (table S1). Sample cross-contamination, which is
common in the field [10,52], was observed in six cells from two
samples with haplogroup status A2 (CB-1; contaminated by
sample CB-2) and J1c (UPN16; contaminated by sample UPN18
or ERR or UPN20), respectively. The contaminant sequences of
the remaining 26 cells did not match any laboratory member, and
the inferred haplogroup status showed that these matrilines were
ultimately of East Asian, sub-Saharan African, Native American,
or West Eurasian origin. Two contaminant types of West Eurasian
ancestry, 16129-73-263-(523-524)delAC and 16239-16519-263,
were observed frequently (eleven and six times, respectively); one
contaminant with East Asian D5a2a status occurred twice (table
S1). The source of these three relatively frequent contaminants
remains enigmatic. Note that the above inferred contamination
from laboratory members and/or samples determined in the same
study might also be contributed by unknown individuals, who by
chance shared identical sequences. That the possibility of such an
occurrence was very low is suggested by our finding only two
laboratory members sharing identical sequence variation among
a total of 41 individuals.
We further located the contaminated cells on the 96-well plate,
to discern whether some wells were more preferentially subjected
to contamination. The occurrence of contamination on the plate
did not show any trend (figure 1C), suggesting that the accidental
entry of external contaminant DNA into a well during experiments
was randomly distributed. Reamplification and resequencing of
the original cell lysates in some cells showing anomaly (about 10%)
failed to reproduce the anomalous sequence and the newly
determined sequence had the consensus sequence expected for
most single cells stemming from the sample. Using the original first
PCR products of these cells as the template and re-performing the
second PCR and sequencing, we consistently detected the
anomalous sequence. This result suggests that contamination in
these cells occurred during the initial PCR amplification process
and not in the pre-PCR stage, or that the potential contaminant
DNA was obscured by preferential amplification of the authentic
mtDNA in the cell in the independent verification experiment.
DISCUSSION
Examining mtDNA mutations at the single-cell level has been
valuable in understanding cell origin and clonality, the potential
mechanism regarding the occurrence and fixation of an mtDNA
mutation by random genetic drift or clonal expansion, and the
mtDNA mutation process in tumor and post-mitotic cells with age
[13–15,22,23,53]. However, one frequently encountered problem
with single-cell and other analyses for mtDNA utilizing tiny amounts
of DNA is contamination, which remains either unrecognized or
unacknowledged in the medical literature. With the available
information about the world mtDNA phylogeny at hand [46–
51,54],we couldeasilydistinguishthebroad geographicoriginof the
anomalous mtDNAs and thus obtain direct evidence of contamina-
tion. For instance, with the new data from the present study, the
extraordinary mtDNA mutation pattern observed in one of the two
CD34
+cellsin[24]couldberesolved:thecontaminantDNApresent
in the bone marrow donor (BM donor 2, U6a1) turned out to be the
haplogroup D4c1a type matching the mtDNA of member 2, who
handled thesampleandperformed theanalysisatthetime[24].This
D4c1a type was also detected in one cell from sample UPN18 that
had a Native American matrilineal ancestry in the current study
(table S1). In the second instance from [24], the cord blood donor
mtDNA(CBdonor1)couldbeclassifiedashaplogroupM30c,which
is specific to South Asian populations [49]. The anomalous sequence
found in one CD34
+ cell from this donor has haplogroup status M39
(based on the shared mutations 153, 463 and 485 with two Indian
M39 lineages from [49]), which is also exclusively South Asian. This
contaminant type was not found among current and past laboratory
Figure 1. Recognition of mtDNA sequence anomalies in single cell
analysis. Sections of representative sequence electropherograms
showing external DNA contamination in a single cell from samples A-
2 (A) and donor 7 (B), together with an uncontaminated cell from the
respective sample. Sites with heteroplasmic mutations (R for A and G; Y
for C and T) were scored relative to the Cambridge Reference Sequence
[3]. (C) Occurrence of contamination events in the wells of the 96-well
plate in analyzing 7094 single cells. The numbers in the wells indicated
the number of contamination instances observed in the respective well.
Wells with no contamination were left empty.
doi:10.1371/journal.pone.0000681.g001
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PLoS ONE | www.plosone.org 4 August 2007 | Issue 8 | e681personnel and its exact source remains unknown. In the present
large-scale study, two characteristics were discerned in the 40
investigated instances: first, the source of 65% of contamination
events could not be explained, as the contaminant sequences did not
match known sequences of either laboratory personnel or other
patient samples involved in the study and three enigmatic
contaminants occurred more than once; second, the risk of
contamination from personnel who did not directly contact the
sample was even higher than for those who handled samples and
performed experiments. The story about the ‘‘flying’’ contaminant
DNA is thus more complicated than we had thought. Fortunately,
the overall rate of external contamination observed in this study was
low and true somatic mutations could be detected in single cells
[13,23] or single cell colonies [24]. In those reports that have
analyzedtheentiremtDNA sequencemutationfrom a smallamount
of cells, such as individual and partial cytochrome c oxidase-positive
or deficient crypts or muscle fibers [14,15,21], the reported mtDNA
alterations appear valid and to correlate with the biochemical
deficiency.
We believe that the observed anomalous mtDNA types are best
explained by contamination rather than potential paternal
leakage, which has only been reported in a single case to date
[55,56]. First, paternal leakage could not account for the three
enigmatic types that were observed multiple times in single cells
from different individuals. Second, we failed to obtain the
anomalous mtDNA type in some cells when using the original
cell lysate as the template in an independent assay, which
suggested that it was most likely introduced during the
amplification process. Third, in a review by one of us of published
instances of putative paternal leakage, based on phylogenetic
criteria, contamination appeared to be the more likely explanation
for the presence of anomalous sequences [42].
Our approach cannot distinguish a contamination event if the
contaminant and the sample show nearly identical sequences (of
the same haplogroup status). For example, in sample UPN19 that
has sequence variants 16519-146-263, contaminant DNA from
laboratory members with the same haplogroup H status (members
16, 24, 26, 27, 35, and 41) and some samples determined in the
same study (donor 8) could not be distinguished by the
phylogenetic method because of the paucity of distinctive
mutations; the heteroplasmic mutations observed in the contam-
inated cells would be naturally regarded as somatic events. In
addition, cross-contamination between different cells of the same
sample is virtually impossible to detect. We fully agree with the
conclusions from recent ancient DNA studies emphasizing that
standard precautions for avoiding contamination are insufficient to
eliminate all contamination [34,35]. In some rare cases, even PCR
reagents could be a source for external DNA contamination [57].
Concerning the question of to what extent we can eliminate
contamination in single-cell analysis, there is no definitive answer –
but a phylogenetic approach as employed here is nevertheless
a useful tool to define the geographic origin of the mtDNA
sequence anomalities. The phylogenetic method can therefore
signal caution in instances in which repeated direct sequence
comparisons appear to have confirmed the authenticity of
observed results; indeed, there is no guarantee that re-analysis
should not suffer from the same systematic error or persistent
contamination as in the initial analysis.
The rate of 0.6% of external contamination observed in this
study while low is not negligible. Unrecognized contamination will
ordinarily be mistaken as evidence towards multiple somatic
mutations and may be associated with the development of diseases,
like the late stage of cancer. The effective contamination rate can
increase by a factor of more than an order of magnitude in some
studies, especially when the researchers did not realize the risk of
contamination and maintain a stringent data control. Indeed, we
recently failed to repeat a high rate of mtDNA somatic mutation in
early stage breast cancer under stringent data quality control [58].
It is not helpful when clear instances of sample confusion or
contamination – discovered through a posteriori analysis – get
subsequently defended as ‘‘real’’ somatic effects by unconvincing
arguments. For example, in a commentary paper on PLoS
Medicine [59], the authors obviously misunderstood the mtDNA
information about Patient 2 from Kirches et al. [60], who codified
mutations not with respect to the reference sequence but contrasted
the nucleotides found in the mtDNAs of glioblastoma and of
corresponding blood sample; the conclusion of Salas et al. [10] that
two mtDNAs from different individuals, one from haplogroup J1c1
and the other from a particular branch of haplogroup U4a, could be
attributed to this patient is logical. Unfortunately, recent review
articles (e.g. [11,12,61]) follow the tradition of early reviews (e.g.
[62,63]) in uncritically listing reported results and ‘‘pioneer’’ articles
(such as [44]) now known to have severely suffered from artifacts.
Nor is it encouraging to see recent recommendations for future
research [64] blind to the problems that have plagued the field of
mtDNA analysis in cancer research.
SUPPORTING INFORMATION
Table S1 mtDNA sequence anomalies identified in single-cell
analysis.
Found at: doi:10.1371/journal.pone.0000681.g001 (0.12 MB
DOC)
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